Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars.
SPEAKERS
Shubha Bhat, PharmD, MS, FCCP, BCACP is a clinical pharmacy specialist in the Digestive Disease & Surgery Institute at the Cleveland Clinic. She received her PharmD from Northeastern University and completed post-graduate residency and fellowship training at Boston Medical Center, University of Illinois at Chicago, and University of Colorado. In her current practice, Dr. Bhat provides medication education, monitors medication outcomes, manages adverse effects, and coordinates health maintenance needs for patients with gastrointestinal conditions. She is also involved in precepting trainees and conducts research focused on ambulatory care pharmacists' impact on patient outcomes and inflammatory bowel disease.
Jorge Garcia, PharmD, MS, MHA, MBA, FACHE obtained his Doctor of Pharmacy and Master of Business Administration from Nova Southeastern University (NSU) in 2010. He then transitioned to the University of Pittsburgh Medical Center (UPMC) to pursue an American Society of Health-System Pharmacy (ASHP)-accredited PGY-1 & PGY-2 Health-System Pharmacy Administration Residency and a Master of Science in Pharmacy Administration. He also completed an Master of Healthcare Administration from Florida Atlantic University (FAU). Dr. García has previously served in the roles of inpatient pharmacy operations coordinator as well as director of pharmacy for system-wide oncology pharmacy services.
Relevant Financial Relationship Disclosures
The following persons in control of this activity’s content have relevant financial relationships:
Shubha Bhat – Pfizer (advisory board); Boehringer Ingelheim (advisory board); Abbvie (consultant); Pharmacosmos (advisory board); Bristol Meyers Squibb (advisory board)
No one else in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Resources
Biosimilar Adoption: Past Experiences and Future Opportunities
Biosimilar Adoption Breaking through Barriers Resource Center
More in This Series
A New Landscape: Biosimilars in Multiple Sclerosis
This podcast is provided by ASHP and sponsored in part by Amgen. Supported in part by an independent medical education grant from Sandoz Inc., a Novartis Division.